+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-13Number of Pages: 101

Parenteral Nutrition Market (By Type of Nutrient - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements and Vitamins and Minerals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Parenteral nutrition refers to the intravenous administration of specialized nutrition solutions such as carbohydrates, single dose amino acids, parenteral lipid emulsions, vitamins and trace elements. This administration method requires when patient’s gastrointestinal track is not working or patients is not adequately nourished by oral or enteral route. This report studies the global parenteral nutrition market in a view of different types of nutrient i.e. carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements. The report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global parenteral nutrition market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Force analysis, event impact analysis and market attractiveness analysis. Additionally, market share analysis in a view of different geographies (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) and different parenteral nutrients (carbohydrates, parenteral lipid emulsion, single dose amino acid solutions, vitamins and minerals and trace elements) have also been covered under the scope of the report.

Based on type of nutrient, the global parenteral nutrition market has been has been extensively analyzed into carbohydrates, single dose amino acid solutions, parenteral lipid emulsion, trace elements, vitamins and minerals. The market size and forecast in terms of USD million for each type of nutrient has been provided for the period from 2013 to 2023. The report on the parenteral nutrition market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the parenteral nutrition market been categorized into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA) which are further divided based on the respective countries. The market size and forecast for each of these regions and countries have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the parenteral nutrition market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc (Actavis plc), Baxter International, Inc., B. Braun Melsungen AG, Claris Lifesciences Limited, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc. (Hospira, Inc.) and others.

The global parenteral nutrition market is segmented as follows:

  • Global Parenteral Nutrition Market, By Type of Nutrient
    • Carbohydrates
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solutions
    • Trace Elements
    • Vitamins and Minerals
  • Global Parenteral Nutrition Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • Taiwan
      • South Korea
      • Rest of APAC
    • Latin America (LATAM)
      • Argentina
      • Mexico
      • Rest of LATAM
    • Middle East and Africa (MEA)
      • Turkey
      • Rest of MEA

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Parenteral Nutrition Market: Market Snapshot
2.2 Global Parenteral Nutrition Market Revenue, by Type of Nutrient, 2014 (US$ Mn)
2.4 Global Parenteral Nutrition Market Share, by Geography (Value %)

Chapter 3 Global Parenteral Nutrition Market– Industry Analysis
3.1 Introduction
3.2 Market Dynamics
       3.2.1 Market Driver
                3.2.1.1 Increase in incidence of chronic diseases
                3.2.1.2 Rise in cases of malnutrition
                3.2.1.3 Approvals of novel parenteral nutrition combinations
                3.2.1.4 Aging population
       3.2.2 Market Restraint
                3.2.2.1 Side effects or complications related to parenteral nutrition products
       3.2.3 Market Opportunity
                3.2.3.1 Expanding footprint in emerging nations that offer sustained growth opportunities
3.3 Porter’s Five Forces Analysis: Global Parenteral Nutrition Market
3.4 Event Impact Analysis: Global Parenteral Nutrition Market
3.5 Market Attractiveness Analysis: Global Parenteral Nutrition Market
3.6 Global Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.1 North America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.2 Europe Market Share – Parenteral Nutrition Market (2014) (%) 
       3.6.3 Asia Pacific Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.4 Latin America Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.5 Middle East & Africa Market Share – Parenteral Nutrition Market (2014) (%)
       3.6.6 Market Share - Carbohydrates Parenteral Nutrition Market (2014) (%)
       3.6.7  Market Share - Parenteral Lipid Emulsion Parenteral Nutrition Market (2014) (%) 
       3.6.8  Market Share - Single Dose Amino Acids Parenteral Nutrition Market (2014) (%) 
       3.6.9 Market Share - Other Parenteral Nutrition Products Market (2014) (%) 

Chapter 4 Market Segmentation - By Type of Nutrient
4.1 Introduction
4.2 Global Parenteral Nutrition Market Revenue, by Types of Nutrient, 2013–2023, (US$ Mn)
       4.2.1 Global Carbohydrates Market Revenue, 2013–2023, (US$ Mn)
       4.2.2 Global Parenteral Lipid Emulsions Market Revenue, 2013–2023, (US$ Mn)
       4.2.3  Global Single Dose Amino Acid Solutions Market Revenue, 2013–2023, (US$ Mn)
       4.2.4 Global Trace Elements Market Revenue, 2013–2023, (US$ Mn)
       4.2.5 Global Vitamins and Minerals Market Revenue, 2013–2023, (US$ Mn)

Chapter 5 Market Segmentation – By Geography
5.1 Global Parenteral Nutrition Market Revenue, by Geography, 2013–2023 (US$ Mn)
5.2 North America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.3 Europe Parenteral Nutrition Market, by Country, 2013–2023 (US$ Mn)
5.4 Asia Pacific Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.5 Latin America Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)
5.6 Middle East & Africa Parenteral Nutrition Market Revenue, by Country, 2013–2023 (US$ Mn)

Chapter 6 Recommendations
6.1 Expand presence in developing economies
6.2 Increase in research and development activities
6.3 Long-term contract with hospitals and community care centers

Chapter 7 Company Profiles
7.1 Allergan plc (Actavis plc)
7.2 Baxter International, Inc.
7.3 B. Braun Melsungen AG
7.4 Claris Lifesciences Limited
7.5 Fresenius SE & Co. KGaA
7.6 Grifols S.A.
7.7 Pfizer, Inc. (Hospira, Inc.)
7.8 Sichuan Kelun Pharmaceutical Co., Ltd.

Parenteral nutrition (PN) is indicated for the patients unable to take sufficient required nutrition via gastrointestinal track for prolonged period. Additionally, PN is necessary when patient cannot be sustained with oral or enteral intake of nutrition supplements. The market for parenteral nutrition is witnessing positive growth majorly due to rising incidence of chronic diseases such as cancer, diabetes and others globally. Additionally, significant increase in cases of preterm babies coupled with malnourished population in developing regions also act as a potential driver for the growth of the market. For example, according to the World Health Organization (WHO), under-nourishment accounts for more than 11% of the global burden of disease and is considered to be the number one risk to health and wellbeing worldwide. The organization also stated that malnutrition contributes around one third of all child deaths globally every year. Other driving factors such as rising approval of novel parenteral nutrition formulations and aging population further boosted the growth of the market to some extent. However, side effects such as catheter infections, refeeding syndrome, particulate contamination and liver dysfunction with parenterally administration of nutrition hampers the global market growth. The global parenteral nutrition market was valued at US$ 4.1 Bn in 2014 and is estimated to reach a market value of US$ 6.9 Bn in 2023 expanding at a CAGR of 5.7% from 2015 to 2023.

The market of global parenteral nutrition market is categorized into major product types such as carbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. Single dose amino acid solutions accounted for the largest market, capturing almost 34.1% share of total parenteral nutrition market in 2014. Growing product approvals coupled with increasing utilization of single dose amino acid solutions by end users drive the market growth in future. However, parenteral lipid emulsion segment is anticipated to grow with the highest CAGR due to potential benefits such as minimal interference with pulmonary hemodynamics and others fuel the uptake of this product, leading to market growth.

Global parenteral nutrition market, by geography is segmented as North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. In 2014, North America dominated the global parenteral nutrition market. Rise in regulatory approval for novel parenteral nutrition coupled with consistent rise in the incidence of chronic diseases in the region stimulated the growth of North America parenteral nutrition market. Europe accounted for the second largest share of the total market in 2014 owing to the favorable growth conditions for pharmaceutical and biotechnology manufacturers due to affordability for branded formulations by consumers. However, Asia Pacific region is estimated to grow with the highest CAGR of 7.3%. Market growth in this region is witnessed due to increasing interest of leading companies such as Baxter, Fresenius and others to establish their presence in Asia Pacific countries such as China and Japan.

Some of the prominent players in the global parenteral nutrition market are Fresenius SE & Co. KGaA, Baxter International, Inc., Grifols S.A., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), B. Braun Melsungen AG, Pfizer, Inc. (Hospira, Inc.) and others.

parenteral-nutrition-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries